raw materials – Page 14

Traceability records incomplete during audit – root cause analysis for mix-ups

Addressing Incomplete Traceability Records During Audits: A Root Cause Analysis Playbook In the dynamic environment of pharmaceutical manufacturing, the integrity of traceability records is pivotal. Incomplete traceability records during an…

Sampler training deficiency during regulatory inspection – inspection-ready sampling justification

Addressing Sampler Training Deficiencies During Regulatory Inspections In the pharmaceutical manufacturing industry, maintaining the integrity of raw material sampling is crucial. During regulatory inspections, deficiencies in sampler training can lead…

Reconciliation discrepancies during warehouse operations – root cause analysis for mix-ups

Addressing Warehouse Reconciliation Discrepancies: A Root Cause Analysis Playbook Reconciliation discrepancies during warehouse operations can lead to severe implications in pharmaceutical manufacturing, including material mix-ups and potential compliance failures. These…

Non-representative sampling detected during internal audit – inspection-ready sampling justification

Investigation of Non-representative Sampling Findings During Internal Audits Non-representative sampling detected during an internal audit presents a serious challenge for pharmaceutical manufacturers and quality control professionals. It can lead to…

Reconciliation discrepancies during audit – inspection defense documentation

Strategies for Managing Reconciliation Discrepancies During Audits Reconciliation discrepancies during audits can pose significant compliance risks in pharmaceutical manufacturing. They often lead to regulatory scrutiny and can even signal underlying…

Sampling SOP not followed during incoming material receipt – CAPA to prevent recurrence

Investigating Non-Compliance with Sampling SOPs During Receipt of Incoming Materials In the demanding world of pharmaceutical manufacturing, adherence to standard operating procedures (SOPs) is paramount. One such critical area is…

Segregation controls inadequate during dispensing – CAPA and system strengthening

Improving Dispensing Practices to Address Inadequate Segregation Controls In recent assessments, numerous pharmaceutical facilities have reported incidents linked to inadequate segregation controls during material dispensing. This issue poses significant risks,…

Sampling SOP not followed during supplier complaint review – root cause analysis for sampling failures

Root Cause Analysis of Deviations in Supplier Complaint Review Sampling Procedures Instances where a sampling SOP not followed during supplier complaint review can have critical implications for product quality and…

Labeling mismatch detected during regulatory inspection – preventing repeat mix-up events

Preventing Labeling Mismatches Identified During Regulatory Inspections Labeling mismatches can lead to significant compliance issues during regulatory inspections, ultimately jeopardizing product integrity and patient safety. In this playbook, pharmaceutical professionals…

Sampling plan not risk-based during incoming material receipt – CAPA to prevent recurrence

Investigating the Non-Risk-Based Sampling Plan During Incoming Material Receipt In today’s pharmaceutical landscape, the integrity of raw materials is paramount. A non-risk-based sampling plan during the receipt of incoming materials…

Labeling mismatch detected during regulatory inspection – traceability system expectations

Managing Labeling Mismatches Detected During a Regulatory Inspection: A Comprehensive Playbook Labeling mismatches can pose significant risks to pharmaceutical manufacturing, particularly during regulatory inspections. When such discrepancies are detected, they…

Non-representative sampling detected during internal audit – CAPA to prevent recurrence

Identifying and Resolving Non-Representative Sampling Issues in Pharmaceutical Manufacturing In the highly regulated pharmaceutical manufacturing environment, maintaining the integrity of raw materials is critical. A recent internal audit revealed a…